Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$63.12 /

-5.16 (-7.56%)

06:10
06/12/20
06/12
06:10
06/12/20
06:10

Bluebird Bio announces new data from Group C of HGB-206 study

Bluebird Bio announced that new data from its ongoing Phase 1/2 HGB-206 study of investigational LentiGlobin gene therapy for adult and adolescent patients with sickle cell disease, or SCD, show a near-complete reduction of serious vaso-occlusive crises, or VOCs, and acute chest syndrome, or ACS. These data are being presented at the Virtual Edition of the 25th European Hematology Association, or EHA25. As of March 3, a total of 37 patients have been treated with LentiGlobin for SCD to-date in the HGB-205 and HGB-206 clinical studies. The HGB-206 total includes: Group A, B and C. In Group C of HGB-206, 25 patients were treated with LentiGlobin for SCD and have up to 24.8 months of follow-up. Results from Group C are as of March 3 and include efficacy data for 16 patients who had at least a Month 6 visit, and safety data for 18 patients, which includes two patients who were at least six months post-treatment but results from a Month 6 visit are not available. In 16 patients with six or more months of follow-up, median levels of gene therapy-derived anti-sickling hemoglobin, HbAT87Q, were maintained with HbAT87Q contributing at least 40% of total hemoglobin. At last visit reported, total hemoglobin ranged from 9.6-16.2 g/dL and HbAT87Q levels ranged from 2.7-9.4 g/dL. At Month 6 the production of HbAT87Q was associated with a reduction in the proportion of HbS in total hemoglobin. Patients had a median of =60% HbS. All patients in Group C were able to stop regular blood transfusions and remain off transfusions at three months post-treatment. There was a 99.5% mean reduction in annualized rate of VOC and ACS among the 14 patients who had at least six months of follow-up and a history of VOCs or ACS, defined as four or more VOC or ACS events in the two years prior to treatment. These 14 patients had a median of eight events in the two years prior to treatment. There were no reports of serious VOCs or ACS at up to 24 months post-treatment in patients with at least six months of follow-up. As previously reported, one non-serious Grade 2 VOC was observed in a patient approximately 3.5 months post-treatment with LentiGlobin for SCD. In sickle cell disease, red blood cells become sickled and fragile, rupturing more easily than healthy red blood cells. The breakdown of red blood cells is hemolysis and this process occurs normally in the body. However, in sickle cell disease hemolysis happens too quickly due to the fragility of the red blood cells, which results in hemolytic anemia. Patients treated with LentiGlobin for SCD demonstrated improvement in key markers of hemolysis, which are indicators of the health of red blood cells. Lab results assessing these indicators were available for the majority of the 18 patients with 6 months of follow-up. The medians for reticulocyte counts (n=15), lactate dehydrogenase, or LDH, levels and total bilirubin improved compared to screening and stabilized by Month 6. In patients with Month 24 data these values approached the upper limit of normal by Month 24. These results suggest treatment with LentiGlobin for SCD is improving biological markers of sickle cell disease. Assays were developed by bluebird bio to enable the detection of HbAT87Q and HbS protein in individual red blood cells as well as to assess if HbAT87Q was pancellular, present throughout all of a patient's red blood cells. Samples from a subset of patients in Group C were assessed. In nine patients who had at least six months of follow-up, the average proportion of red blood cells positive for HbAT87Q was greater than 70%, and on average more than 85% of red blood cells contained HbAT87Q at 18 months post-treatment, suggesting near-complete pancellularity of HbAT87Q distribution. As of March 3, the safety data from all patients in HGB-206 are generally reflective of underlying SCD and the known side effects of hematopoietic stem cell collection and myeloablative conditioning. There were no serious adverse events related to LentiGlobin for SCD, and the non-serious, related adverse events, or AEs, were mild-to-moderate in intensity and self-limited. One patient with a history of frequent pre-treatment VOE, pulmonary and systemic hypertension, venous thrombosis, obesity, sleep apnea and asthma had complete resolution of VOEs following treatment, but suffered sudden death 20 months after treatment with LentiGlobin for SCD. The patient's autopsy revealed cardiac enlargement and fibrosis, and concluded the cause of death was cardiovascular, with contributions from SCD and asthma. The treating physician and an independent monitoring committee agreed this death was unlikely related to LentiGlobin for SCD gene therapy.

  • 18

    Jun

BLUE Bluebird Bio
$63.12 /

-5.16 (-7.56%)

06/10/20 Stifel
Stifel says Bluebird setup 'downside biased,' Crispr's 'upside biased' into EHA
05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 RBC Capital
Bluebird Bio initiated with an Outperform at RBC Capital

TODAY'S FREE FLY STORIES

General news
Treasury's $61 B 5-year sale was rather tepid » 13:20
06/23/21
06/23
13:20
06/23/21
13:20
$ECON

Economic Data

/

+

Treasury's $61 B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Technical Analysis
NASDAQ market internals summary » 13:17
06/23/21
06/23
13:17
06/23/21
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 13:16
06/23/21
06/23
13:16
06/23/21
13:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Hot Stocks
North American rail traffic rose 10.6% in week ended June 19, AAR says » 13:14
06/23/21
06/23
13:14
06/23/21
13:14
CNI

Canadian National

$105.51 /

-0.05 (-0.05%)

, CP

Canadian Pacific

$76.23 /

-0.26 (-0.34%)

, CSX

CSX

$95.11 /

-0.16 (-0.17%)

, KSU

Kansas City Southern

$284.26 /

+0.69 (+0.24%)

, NSC

Norfolk Southern

$265.02 /

+0.97 (+0.37%)

, UNP

Union Pacific

$220.16 /

+1.155 (+0.53%)

, GWR

Genesee & Wyoming

$111.91 /

+ (+0.00%)

The Association of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$105.51 /

-0.05 (-0.05%)

CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

CSX CSX
$95.11 /

-0.16 (-0.17%)

KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

NSC Norfolk Southern
$265.02 /

+0.97 (+0.37%)

UNP Union Pacific
$220.16 /

+1.155 (+0.53%)

GWR Genesee & Wyoming
$111.91 /

+ (+0.00%)

CNI Canadian National
$105.51 /

-0.05 (-0.05%)

06/21/21 Stifel
Canadian National resumed with a Hold at Stifel
05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

06/21/21 Stifel
Canadian Pacific resumed with a Hold at Stifel
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
05/26/21 Desjardins
Canadian Pacific price target adjusted to reflect 5-for-1 split at Desjardins
05/25/21 Evercore ISI
Kansas City Southern resumed at In Line from Outperform at Evercore ISI
CSX CSX
$95.11 /

-0.16 (-0.17%)

06/21/21 Stifel
CSX resumed with a Hold at Stifel
06/15/21 Deutsche Bank
CSX price target raised to $115 from $113 at Deutsche Bank
05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
04/21/21 Deutsche Bank
CSX price target raised to $113 from $105 at Deutsche Bank
KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

06/21/21 Stifel
Canadian Pacific resumed with a Hold at Stifel
06/21/21 Stifel
Canadian National resumed with a Hold at Stifel
05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
NSC Norfolk Southern
$265.02 /

+0.97 (+0.37%)

06/21/21 Stifel
Norfolk Southern resumed with a Hold at Stifel
05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
05/04/21 Argus
Norfolk Southern price target raised to $310 from $275 at Argus
04/29/21 BMO Capital
Norfolk Southern price target raised to $285 from $250 at BMO Capital
UNP Union Pacific
$220.16 /

+1.155 (+0.53%)

06/21/21 Stifel
Union Pacific resumed with a Hold at Stifel
06/15/21 Deutsche Bank
Union Pacific price target raised to $256 from $252 at Deutsche Bank
05/28/21 Barclays
Union Pacific price target raised to $240 from $230 at Barclays
04/26/21 Deutsche Bank
Union Pacific price target raised to $252 from $239 at Deutsche Bank
GWR Genesee & Wyoming
$111.91 /

+ (+0.00%)

CNI Canadian National
$105.51 /

-0.05 (-0.05%)

CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

CSX CSX
$95.11 /

-0.16 (-0.17%)

KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

NSC Norfolk Southern
$265.02 /

+0.97 (+0.37%)

UNP Union Pacific
$220.16 /

+1.155 (+0.53%)

CNI Canadian National
$105.51 /

-0.05 (-0.05%)

CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

UNP Union Pacific
$220.16 /

+1.155 (+0.53%)

CNI Canadian National
$105.51 /

-0.05 (-0.05%)

CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

CSX CSX
$95.11 /

-0.16 (-0.17%)

KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

CNI Canadian National
$105.51 /

-0.05 (-0.05%)

CP Canadian Pacific
$76.23 /

-0.26 (-0.34%)

CSX CSX
$95.11 /

-0.16 (-0.17%)

KSU Kansas City Southern
$284.26 /

+0.69 (+0.24%)

UNP Union Pacific
$220.16 /

+1.155 (+0.53%)

General news
5-year note auction » 13:09
06/23/21
06/23
13:09
06/23/21
13:09
$ECON

Economic Data

/

+

Total Amount: $61B, Rate:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Conference/Events
Crowdstrike participates in a conference call with Truist » 13:06
06/23/21
06/23
13:06
06/23/21
13:06
CRWD

Crowdstrike

$254.28 /

-2.345 (-0.91%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

06/22/21
Fly Intel: Top five analyst upgrades
06/21/21 Stifel
Crowdstrike upgraded to Buy from Hold at Stifel
06/21/21 Stifel
Crowdstrike upgraded to Buy from Hold at Stifel
06/04/21 RBC Capital
Crowdstrike price target raised to $259 from $250 at RBC Capital
CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

  • 26
    Jun
CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

CRWD Crowdstrike
$254.28 /

-2.345 (-0.91%)

Hot Stocks
Establishment Labs breaks ground on third facility in Costa Rica » 13:05
06/23/21
06/23
13:05
06/23/21
13:05
ESTA

Establishment Labs

$81.06 /

+2.1 (+2.66%)

Establishment Labs held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESTA Establishment Labs
$81.06 /

+2.1 (+2.66%)

ESTA Establishment Labs
$81.06 /

+2.1 (+2.66%)

09:33 Today BTIG
Establishment Labs price target raised to $88 from $82 at BTIG
02/10/21 Cowen
Establishment Labs price target raised to $80 from $60 at Cowen
01/13/21 BTIG
Establishment Labs price target raised to $61 from $41 at BTIG
01/12/21 Jefferies
Allergan exits a 'clear win' for Establishment Labs, says Jefferies
ESTA Establishment Labs
$81.06 /

+2.1 (+2.66%)

Options
Rocket Companies call volume above normal and directionally bullish » 13:05
06/23/21
06/23
13:05
06/23/21
13:05
RKT

Rocket Companies

$19.61 /

+0.49 (+2.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Argus
Rocket Companies initiated with a Buy at Argus
06/08/21 Argus
Rocket Companies initiated with a Buy at Argus
06/08/21 Piper Sandler
Rocket Companies initiated with a Neutral at Piper Sandler
RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

  • 06
    Aug
RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

RKT Rocket Companies
$19.61 /

+0.49 (+2.56%)

Conference/Events
Sangamo participates in a conference call with Truist » 13:04
06/23/21
06/23
13:04
06/23/21
13:04
SGMO

Sangamo

$11.55 /

+0.09 (+0.79%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGMO Sangamo
$11.55 /

+0.09 (+0.79%)

SGMO Sangamo
$11.55 /

+0.09 (+0.79%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
SGMO Sangamo
$11.55 /

+0.09 (+0.79%)

SGMO Sangamo
$11.55 /

+0.09 (+0.79%)

Conference/Events
Truist healthcare/pharma analysts hold an analyst/industry conference call » 13:02
06/23/21
06/23
13:02
06/23/21
13:02
BIIB

Biogen

$366.01 /

-8.58 (-2.29%)

Healthcare &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$366.01 /

-8.58 (-2.29%)

BIIB Biogen
$366.01 /

-8.58 (-2.29%)

06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 Piper Sandler
Biogen upgraded to Overweight from Neutral at Piper Sandler
BIIB Biogen
$366.01 /

-8.58 (-2.29%)

BIIB Biogen
$366.01 /

-8.58 (-2.29%)

BIIB Biogen
$366.01 /

-8.58 (-2.29%)

BIIB Biogen
$366.01 /

-8.58 (-2.29%)

Recommendations
Kinross Gold price target lowered to $11 from $11.50 at TD Securities » 12:59
06/23/21
06/23
12:59
06/23/21
12:59
KGC

Kinross Gold

$6.45 /

+0.095 (+1.49%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGC Kinross Gold
$6.45 /

+0.095 (+1.49%)

KGC Kinross Gold
$6.45 /

+0.095 (+1.49%)

12:37 Today BMO Capital
Kinross Gold price target lowered to $11.50 from $13 at BMO Capital
12:29 Today Stifel
Kinross Gold price target lowered to C$14.25 from C$14.50 at Stifel
06:00 Today Credit Suisse
Kinross Gold upgraded to Outperform from Neutral at Credit Suisse
06/22/21
Fly Intel: Top five analyst downgrades
KGC Kinross Gold
$6.45 /

+0.095 (+1.49%)

KGC Kinross Gold
$6.45 /

+0.095 (+1.49%)

Recommendations
Summit Industrial Income REIT price target raised to C$18.50 from C$16.50 at Scotiabank » 12:57
06/23/21
06/23
12:57
06/23/21
12:57
SMMCF

Summit Industrial Income REIT

$14.21 /

+0.41189 (+2.99%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMCF Summit Industrial Income REIT
$14.21 /

+0.41189 (+2.99%)

12:49 Today CIBC
Summit Industrial Income REIT price target raised to C$18 from C$16.50 at CIBC
06/22/21 BMO Capital
Summit Industrial price target raised to C$18.50 from C$16.75 at BMO Capital
05/18/21 RBC Capital
Summit Industrial price target raised to C$17.50 from C$15.50 at RBC Capital
05/14/21 BMO Capital
Summit Industrial price target raised to C$16.75 from C$15 at BMO Capital
Recommendations
Granite Real Estate price target raised to C$91 from C$90 at Scotiabank » 12:56
06/23/21
06/23
12:56
06/23/21
12:56
GRP

Granite Real Estate

$38.91 /

+ (+0.00%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRP Granite Real Estate
$38.91 /

+ (+0.00%)

06/11/21 National Bank
Granite Real Estate price target raised to C$90 from C$88.50 at National Bank
06/10/21 Raymond James
Granite Real Estate price target raised to C$91 from C$90 at Raymond James
06/10/21 TD Securities
Granite Real Estate price target raised to C$92 from C$89 at TD Securities
05/11/21 Desjardins
Granite Real Estate price target raised to C$88 from C$84 at Desjardins
Recommendations
Dream Industrial price target raised to C$16.50 from C$16 at Scotiabank » 12:55
06/23/21
06/23
12:55
06/23/21
12:55
DREUF

Dream Industrial

$11.99 /

+ (+0.00%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DREUF Dream Industrial
$11.99 /

+ (+0.00%)

06/02/21 Scotiabank
Dream Industrial price target raised to C$16 from C$15 at Scotiabank
06/01/21 CIBC
Dream Industrial price target raised to C$15.50 from C$15 at CIBC
06/01/21 TD Securities
Dream Industrial price target raised to C$16 from C$15.50 at TD Securities
05/20/21 Canaccord
Dream Industrial price target raised to C$16 from C$15 at Canaccord
Recommendations
Equinox Gold price target lowered to C$16.75 from C$17.25 at Scotiabank » 12:54
06/23/21
06/23
12:54
06/23/21
12:54
EQX

Equinox Gold

$7.22 /

-0.44 (-5.74%)

Scotiabank analyst Ovais…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQX Equinox Gold
$7.22 /

-0.44 (-5.74%)

EQX Equinox Gold
$7.22 /

-0.44 (-5.74%)

12:44 Today CIBC
Equinox Gold price target lowered to C$11.50 from C$14 at CIBC
12:37 Today BMO Capital
Equinox Gold price target lowered to C$18.50 from C$20 at BMO Capital
06/01/21 RBC Capital
Equinox Gold initiated with a Sector Perform at RBC Capital
05/21/21
Fly Intel: Top five analyst initiations
EQX Equinox Gold
$7.22 /

-0.44 (-5.74%)

Recommendations
Torex Gold Resources price target lowered to C$23.50 from C$26.50 at CIBC » 12:50
06/23/21
06/23
12:50
06/23/21
12:50
TORXF

Torex Gold Resources

$12.21 /

-0.21258 (-1.71%)

CIBC analyst Bryce Adams…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TORXF Torex Gold Resources
$12.21 /

-0.21258 (-1.71%)

06/17/21 BMO Capital
Torex Gold Resources price target lowered to C$28 from C$29 at BMO Capital
06/17/21 Scotiabank
Torex Gold Resources price target lowered to C$22 from C$24 at Scotiabank
06/01/21 RBC Capital
Torex Gold Resources assumed with a Sector Perform at RBC Capital
05/14/21 BMO Capital
Torex Gold Resources price target lowered to C$29 from C$30 at BMO Capital
Recommendations
Toronto-Dominion price target lowered to C$95 from C$97 at CIBC » 12:50
06/23/21
06/23
12:50
06/23/21
12:50
TD

Toronto-Dominion

$70.74 /

-0.09 (-0.13%)

CIBC analyst Paul Holden…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TD Toronto-Dominion
$70.74 /

-0.09 (-0.13%)

TD Toronto-Dominion
$70.74 /

-0.09 (-0.13%)

06/15/21 National Bank
Toronto-Dominion price target raised to C$91 from C$89 at National Bank
06/07/21 Credit Suisse
Toronto-Dominion price target raised to C$87 from C$85 at Credit Suisse
05/28/21 RBC Capital
Toronto-Dominion price target raised to C$91 from C$82 at RBC Capital
05/28/21 Credit Suisse
Toronto-Dominion price target raised to C$85 from C$84 at Credit Suisse
TD Toronto-Dominion
$70.74 /

-0.09 (-0.13%)

TD Toronto-Dominion
$70.74 /

-0.09 (-0.13%)

TD Toronto-Dominion
$70.74 /

-0.09 (-0.13%)

Recommendations
Summit Industrial Income REIT price target raised to C$18 from C$16.50 at CIBC » 12:49
06/23/21
06/23
12:49
06/23/21
12:49
SMMCF

Summit Industrial Income REIT

$14.21 /

+0.41189 (+2.99%)

CIBC analyst Dean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMCF Summit Industrial Income REIT
$14.21 /

+0.41189 (+2.99%)

06/22/21 BMO Capital
Summit Industrial price target raised to C$18.50 from C$16.75 at BMO Capital
05/18/21 RBC Capital
Summit Industrial price target raised to C$17.50 from C$15.50 at RBC Capital
05/14/21 BMO Capital
Summit Industrial price target raised to C$16.75 from C$15 at BMO Capital
05/14/21 Desjardins
Summit Industrial Income price target raised to C$17 from C$15.50 at Desjardins
Recommendations
Royal Bank of Canada price target lowered to C$131 from C$133 at CIBC » 12:48
06/23/21
06/23
12:48
06/23/21
12:48
RY

Royal Bank of Canada

$102.49 /

+0.12 (+0.12%)

CIBC analyst Paul Holden…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$102.49 /

+0.12 (+0.12%)

RY Royal Bank of Canada
$102.49 /

+0.12 (+0.12%)

06/15/21 National Bank
Royal Bank of Canada price target raised to C$140 from C$137 at National Bank
06/07/21 Credit Suisse
Royal Bank of Canada price target raised to C$135 from C$132 at Credit Suisse
05/28/21 BMO Capital
Royal Bank of Canada price target raised to C$139 from C$131 at BMO Capital
05/28/21 Credit Suisse
Royal Bank of Canada price target raised to C$132 from C$125 at Credit Suisse
RY Royal Bank of Canada
$102.49 /

+0.12 (+0.12%)

Recommendations
Pretium Resources price target lowered to C$14.50 from C$16 at CIBC » 12:48
06/23/21
06/23
12:48
06/23/21
12:48
PVG

Pretium Resources

$9.99 /

-0.02 (-0.20%)

CIBC analyst Anita Soni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVG Pretium Resources
$9.99 /

-0.02 (-0.20%)

PVG Pretium Resources
$9.99 /

-0.02 (-0.20%)

06/01/21 RBC Capital
Pretium Resources assumed with a Sector Perform at RBC Capital
05/20/21 National Bank
Pretium Resources price target raised to C$16.50 from C$16 at National Bank
04/21/21 Canaccord
Pretium Resources downgraded to Hold from Speculative Buy at Canaccord
01/19/21 National Bank
Pretium Resources price target lowered to C$17 from C$19 at National Bank
PVG Pretium Resources
$9.99 /

-0.02 (-0.20%)

Recommendations
Osisko Gold price target raised to C$22.50 from C$21 at CIBC » 12:47
06/23/21
06/23
12:47
06/23/21
12:47
OR

Osisko Gold

$14.10 /

+0.01 (+0.07%)

CIBC analyst Cosmos Chiu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OR Osisko Gold
$14.10 /

+0.01 (+0.07%)

OR Osisko Gold
$14.10 /

+0.01 (+0.07%)

06/04/21 CIBC
Osisko Gold price target raised to C$21 from C$19.50 at CIBC
05/20/21 National Bank
Osisko Gold price target raised to C$21.50 from C$20 at National Bank
05/20/21 Canaccord
Maverix Metals upgraded to Buy from Hold at Canaccord
05/13/21 Raymond James
Osisko Gold price target raised to C$22 from C$21.50 at Raymond James
OR Osisko Gold
$14.10 /

+0.01 (+0.07%)

Recommendations
OceanaGold price target raised to C$3 from C$2.85 at CIBC » 12:47
06/23/21
06/23
12:47
06/23/21
12:47
OCANF

OceanaGold

$1.97 /

-0.01 (-0.51%)

CIBC analyst Cosmos Chiu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCANF OceanaGold
$1.97 /

-0.01 (-0.51%)

05/20/21 National Bank
OceanaGold price target raised to C$3.50 from C$3 at National Bank
05/05/21 Canaccord
OceanaGold downgraded to Hold from Buy at Canaccord
05/03/21 Macquarie
OceanaGold downgraded to Underperform from Neutral at Macquarie
04/23/21 National Bank
OceanaGold price target lowered to C$3 from C$3.25 at National Bank
Recommendations
Nomad Royalty price target lowered to C$12.50 from C$13.50 at CIBC » 12:47
06/23/21
06/23
12:47
06/23/21
12:47
NSRXD

Nomad Royalty

$7.31 /

-0.12 (-1.62%)

CIBC analyst Anita Soni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSRXD Nomad Royalty
$7.31 /

-0.12 (-1.62%)

06/22/21 Raymond James
Nomad Royalty price target lowered to C$17.50 from C$18 at Raymond James
06/14/21 Scotiabank
Nomad Royalty price target raised to C$17 from C$1.50 at Scotiabank
06/09/21 Stifel
Nomad Royalty price target adjusted following share consolidation at Stifel
Periodicals
Stellantis, Russian Railways put Gefco up for sale, Reuters reports » 12:46
06/23/21
06/23
12:46
06/23/21
12:46
STLA

Stellantis

$20.27 /

+0.01 (+0.05%)

Russian Railways and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLA Stellantis
$20.27 /

+0.01 (+0.05%)

STLA Stellantis
$20.27 /

+0.01 (+0.05%)

05/06/21 Societe Generale
Stellantis price target raised to EUR 20 from EUR 18.50 at Societe Generale
03/29/21 Jefferies
Stellantis price target raised to $25 from $22 at Jefferies
03/23/21 Kepler Cheuvreux
Autos upgraded to Overweight from Neutral at Kepler Cheuvreux
03/15/21 JPMorgan
Stellantis price target raised to EUR 20 from EUR 18 at JPMorgan
STLA Stellantis
$20.27 /

+0.01 (+0.05%)

STLA Stellantis
$20.27 /

+0.01 (+0.05%)

STLA Stellantis
$20.27 /

+0.01 (+0.05%)

Recommendations
MAG Silver price target raised to C$33 from C$29 at CIBC » 12:45
06/23/21
06/23
12:45
06/23/21
12:45
MAG

MAG Silver

$22.11 /

+0.18 (+0.82%)

CIBC analyst Alex Hunchak…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAG MAG Silver
$22.11 /

+0.18 (+0.82%)

MAG MAG Silver
$22.11 /

+0.18 (+0.82%)

06/09/21 Raymond James
MAG Silver price target raised to C$28 from C$27 at Raymond James
05/20/21 National Bank
MAG Silver price target raised to C$28.25 from C$27 at National Bank
05/20/21 Raymond James
MAG Silver price target raised to C$27 from C$26.50 at Raymond James
05/19/21 CIBC
MAG Silver price target raised to C$29 from C$27 at CIBC
MAG MAG Silver
$22.11 /

+0.18 (+0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.